Chemoinformaics analysis of Dihydroalpinumisoflavone
| Molecular Weight | 338.359 | nRot | 1 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 23 |
| Exact Molecular Weight | 338.115 | nRing | 4 |
| Solubility: LogS | -3.696 | nHRing | 2 |
| Solubility: LogP | 4.411 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 49.4123 |
| nHD | 2 | BPOL | 22.3977 |
| QED | 0.702 |
| Synth | 2.745 |
| Natural Product Likeliness | 1.685 |
| NR-PPAR-gamma | 0.981 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.004 |
| HIA | 0.009 |
| CACO-2 | -4.681 |
| MDCK | 0.0000182 |
| BBB | 0.022 |
| PPB | 0.994853 |
| VDSS | 0.47 |
| FU | 0.00886637 |
| CYP1A2-inh | 0.873 |
| CYP1A2-sub | 0.488 |
| CYP2c19-inh | 0.842 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.727 |
| CYP2c9-sub | 0.943 |
| CYP2d6-inh | 0.52 |
| CYP2d6-sub | 0.686 |
| CYP3a4-inh | 0.25 |
| CYP3a4-sub | 0.133 |
| CL | 3.607 |
| T12 | 0.444 |
| hERG | 0.028 |
| Ames | 0.065 |
| ROA | 0.475 |
| SkinSen | 0.585 |
| Carcinogencity | 0.437 |
| EI | 0.238 |
| Respiratory | 0.088 |
| NR-Aromatase | 0.874 |
| Antiviral | Yes |
| Prediction | 0.850774 |